Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID‐19 vaccine case report-Reference-Cited by-同舟云学术

Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID‐19 vaccine case report

Published:2023-02 Issue:2 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Gonzalez Susan¹^ORCID,Levine David M.¹²^ORCID

Affiliation:

1. Harvard Medical School Boston Massachusetts USA

2. Division of General Internal Medicine and Primary Care Brigham and Women's Hospital Boston Massachusetts USA

Abstract

AbstractWe describe a case of an otherwise healthy 60‐year‐old female patient who presented 6 days after receipt of the second dose of the BNT162b2 mRNA COVID‐19 (Pfizer/BioNTech) vaccine and was found to have upper extremity deep venous thrombosis.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.6012

Reference17 articles.

1. CDC COVID Data Tracker. Centers for Disease Control and Prevention.http://covid.cdc.gov/covid‐data‐tracker/. Accessed December 20 2021.

2. United States Department of Health and Human Services (DHHS) Public Health Service (PHS) Centers for Disease Control (CDC)/Food and Drug Administration (FDA) Vaccine Adverse Event Reporting System (VAERS) 1990–12/10/2021 CDC WONDERhttp://wonder.cdc.gov/vaers.html/. Accessed December 20 2021.

3. Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

4. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

5. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report;Clinical Case Reports;2023-06

2. Autoimmunity in context of exposure to SARS-Cov2 virus;Pneumologia;2023-01-01